.gamma.-secretase in vitro test system
CA 2381952 A1 · Owner: Fuchs, Klaus · Inventors: Fechteler, Katja; Fuchs, Klaus; Kostka, Marcus
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method for identifying specific .gamma.-secretase inhibitors which can be used for treating neuro-degenerative diseases in , particular to a method which can be carried out in vitro. The invention also relates to a test kit which can be used for said method in addition to the , use of this test kit or method to identify substances which specifically inhibit .gamma.-secretase. A further embodiment relates to the use of these substances to produce a medicament for treating neuro-degenerative diseases and to pharmaceutical formulations which contain said substances.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 25, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 25, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 25, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.